Efterpi Z.
- Country
- Greece
- Department
- Dermatology Department
Research Overview
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
- Efficacy and Safety of Daxdilimab in Adults with Moderate-to-Severe Primary Discoid Lupus Erythematosus: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of IMVT-1402 Efficacy and Safety in Active Subacute and Chronic Cutaneous Lupus Erythematosus: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 65 of 248 partner sites.
Specializations
Autoimmune and connective tissue diseases
Clinical research activity includes systemic lupus erythematosus, cutaneous lupus erythematosus, Sjögren’s syndrome, dermatomyositis, polymyositis, and systemic sclerosis, with additional interest in broader immune-mediated inflammatory disorders.
- Systemic lupus erythematosus
- Sjögren’s syndrome
- Dermatomyositis and polymyositis
- Systemic sclerosis
Therapeutic focus extends to immunomodulatory and anti-inflammatory strategies for chronic autoimmune skin and systemic disease.
Inflammatory skin disease and dermatologic immunotherapy
The investigator is involved in trials spanning atopic dermatitis, hidradenitis suppurativa, non-infectious uveitis, and vernal keratoconjunctivitis, reflecting a strong dermatology-linked interest in inflammatory and immune-driven conditions.
- Atopic dermatitis
- Hidradenitis suppurativa
- Non-infectious uveitis
- Vernal keratoconjunctivitis
Relevant therapeutic domains include biologic therapy, targeted immune modulation, and treatment of chronic relapsing inflammatory skin disease.
Respiratory and interstitial lung disorders
Research involvement covers idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, progressive pulmonary fibrosis, pulmonary arterial hypertension, chronic obstructive pulmonary disease, and bronchiectasis.
- Idiopathic pulmonary fibrosis
- Systemic sclerosis-associated interstitial lung disease
- Progressive pulmonary fibrosis
- Pulmonary arterial hypertension
The therapeutic emphasis is on fibrotic lung disease, airway inflammation, and pulmonary vascular disease.
Cardiovascular and thrombotic disease prevention
The investigator participates in studies of acute ischemic stroke, atrial fibrillation, heart failure, acute coronary syndrome, hypertension, and atherosclerotic cardiovascular disease, with a notable preventive medicine orientation.
- Acute ischemic stroke
- Atrial fibrillation
- Heart failure
- Atherosclerotic cardiovascular disease
Therapeutic interest includes antithrombotic care, cardiovascular risk reduction, and management of inflammatory cardiovascular disease.
Metabolic, neurologic, and ophthalmic disorders
Additional clinical trial activity spans type 2 diabetes, obesity, multiple sclerosis, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and neovascular age-related macular degeneration.
- Type 2 diabetes and obesity
- Multiple sclerosis
- Generalized myasthenia gravis
- Neovascular age-related macular degeneration
This portfolio reflects interest in metabolic disease, neuroimmunology, and retinal vascular disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.